OutofPocket Payments in Indonesias National Health Insurance (JKN)
Indonesias National Health Insurance scheme, Jaminan Kesehatan Nasional (JKN), was launched in 2014 with the aim of providing universal health coverage (UHC) to the countrys 270million residents. While JKN has dramatically increased access to formal health services, outofpocket (OOP) payments remain a significant barrier for many Indonesians. This page explains why OOP payments occur under JKN, their impact on households, and the policies that try to limit them.
JKN is primarily financed through three sources:
These contributions create a pooled fund managed by the Social Security Administration for Health (BPJSKesehatan), which then contracts public and private providers to deliver a defined benefit package.
OOP payments are any expenses that patients pay directly to providers that are not reimbursed by JKN. Typical OOP items include:
Although JKNs reference package is extensive, it does not cover every drug, procedure, or technology. When a needed item falls outside the package, patients must pay.
Many public hospitals face shortages of essential medicines and equipment. To maintain service continuity, they may charge patients for the missing items. Private providers, who are reimbursed at lower rates than public facilities, sometimes add supplementary charges.
JKN operates a tiered referral system (primary secondary tertiary). If a patient bypasses a lowerlevel facility without a proper referral, the insurer may deem the service nonbenefit, leading to OOP billing.
Complex paperwork, delayed claim processing, and lack of electronic verification can result in providers asking patients to pay upfront and claim reimbursement later, a practice that many cannot afford.
In some regions, patients report giving small cash gifts to ensure timely attention. While not officially sanctioned, these payments add to the OOP burden.
OOP expenditures can push families into catastrophic health spending (exceeding 10% of total household consumption) and impoverishment. A 2022 BMJ Global Health analysis found that 6% of Indonesian households experienced catastrophic health expenditure, with the highest incidence among lowincome groups in rural areas.
Key consequences include:
BPJSKesehatan regularly updates the list of covered drugs and procedures. Recent additions include newly approved oncology drugs and advanced imaging services.
Investment in community health centers (Puskesmas) aims to keep patients within the referral hierarchy, lowering the need for expensive tertiary care.
Transitioning from feeforservice to bundled payments and capitation encourages providers to manage resources efficiently and reduces the incentive to charge extra fees.
The JKN Mobile app enables realtime eligibility checks, decreasing the likelihood of upfront payments.
The government provides additional cash assistance (BLTB) to families who experience catastrophic OOP expenses, helping to mitigate the financial shock.
Achieving true universal health coverage in Indonesia will require continued reduction of OOP spending. Ongoing reformssuch as a universal drug price negotiation mechanism, expanded digital health records, and stronger enforcement of the referral systemshow promise. Monitoring OOP trends through household surveys and integrating patient feedback into policy design are essential steps toward a more equitable health system.
For the latest updates on JKN policies, visit the official BPJSKesehatan website.
All data referenced are based on publicly available reports up to 2024. Figures may have changed after this date.
